Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
MARKET
COMPLAINTS
INVESTIGATION AND
RECALL
DHANJAY KUMAR SINGH
(Sr. Executive QA)
SIMPEX PHARMA PVT. LTD., KOTDWAR
2
MARKET COMPLAINTS
INTRODUCTION
A complaint is an objection to something that is unfair,
unacceptable, or otherwise not up to normal standards.
 Complaints may be about Services, Delivery, Quality of
Product, Communication, Response, Time, Documentation,
Billing, Follow up etc.
 Complaint is any communication written or verbal, received
directly from any customer, retailer, distributor, or
representative of contract giver, regarding the quality
attributes, labelling defects or any other matter such
complaints shall be considered as market complaints.
3
Handling of Product Complaints
Section 820.3(b) of the Quality Systems regulation defines
a complaint as "any written, electronic, or oral communication that alleges
deficiencies related to the identity, quality, durability, reliability, safety,
effectiveness, or performance of a device after it is released for distribution”.
We (Simpex) define complaint as –
“any written or verbal communication received from any customer including
qualified personnel, pharmacy, retailer, distributor, or regulatory authorities
regarding the purity, safety, strength, efficacy, labeling, shortage or any
other issue which claim to be related to the quality of the product/packing in
the opinion of the complainer”.
4
Why do customers complain?
Their expectations have not been met…!
When the customer pays for a product or service, it is assumed that the
product will work correctly or that the service received is as promised. Ideally,
the customer will be satisfied, and there will be no complaints.
5
 It gives the company an opportunity to
improve the quality of the product
It is helpful to maintain cGMP
It maintains committed relationship between
the customer and company
It is the regulatory obligation.
NEED FOR COMPLAINT HANDLING SYSTEM
Classification of complaints
A-Type Complaints
Critical complaints in which product is required to be withdrawn
from the market. (Primary Response shall be given within working hours of same
day of the receipt of market complaint)
Such as
• Adverse Drug Reaction.
• Major health hazard causing permanent deficiency or death.
• Purity & Safety.
• Potency.
• Product Stability
Classification of complaints
B-Type Complaints
Major complaints (Primary response to Major defects shall be given within 24
hours of the receipt of the market complaint)
such as
• Problem with primary packaging of the product.
• Chemical / Physical attributes of the product.
• Extraneous contamination, mix-ups, etc.
Classification of complaints
C-Type Complaints
Minor complaints (Primary response to Major defects shall be given within 72
hours of the receipt of the market complaint)
such as
• Problem related to labelling / coding of batch details.
• Shortages.
• Secondary packaging material problem, etc.
9
ComplaintsHandling
STEPS INVOLVED IN HANDLING OF COMPLAINTS
Step I: Receiving
Step II: Investigation
Step III: Corrective Actions
Step IV: Feedback to Customers
10
Complaint flow at manufacturing unit …
Reporting
Track action
Acknowledgment Team formation Investigation
Sample check
Record review
Machine review
Expert advice
Action
Investigation
report
Response
11
PRODUCT RECALL
What is
PRODUCT RECALL?
12
PRODUCT RECALL
Recalls are actions taken to remove a product
from the market and restrict further distribution
and sale – Simpex (SQA013)
A recall is when a product is removed from the
market… because it is either defective or
potentially harmful. – US FDA
Permanent removal of therapeutic goods from
supply or use for reasons relating to deficiencies
in the quality, safety or efficacy of goods. –
Therapeutic Goods Administration, Australia
13
PRODUCT RECALL
There should be a system to recall from the
market, promptly and effectively, products known
or suspected to be defective. – WHO
In order to protect public health… necessary to
implement urgent measures such as the recall of
one or more defective batch(es) of a medicinal
product from the market. – European Medicines
Agency (EMA)
14
RECALL CLASSIFICATION
Class 1 Recall
Situation in which there is a reasonable
probability that the use or exposure to the
product will cause serious adverse health
consequences or death.
15
RECALL CLASSIFICATION
Class 2 Recall
Situation in which use or exposure to the
product may cause temporary or medically
reversible adverse health consequences or
where the probability of serious adverse
health consequences
is remote.
16
RECALL CLASSIFICATION
Class 3 Recall
Situation in which use or exposure to the
product is not likely to cause adverse health
consequences.
17
DURATION OF RECALL OPERATION
 Class 1 Recall – Within 24hr to
Maximum 72 hr.
 Class 2 Recall – Within 10 days
 Class 3 Recall – Within 30 days
18
TYPE OF RECALL
 VOLUNTARY RECALL:
This is recall of product from the market or distribution
network of entire available quantity at the time of initiation
of recall, based on decision by Recall Management
Committee. This could be because of:
quality complaint from market, or
discovery of some deficiency, or
stability problem subsequent to dispatch, or
unsold stocks (short expiry)
FORCED RECALL:
This is recall forced by a regulatory agency upon discovery /
reporting of violation or deficiency in the product.
19
PRODUCT RECALL
WHO WILL
INITIATE
THE RECALL?
20
PRODUCT RECALL
 Head QA shall take the decision on recall in consultation with
management of firm including key personnel involved in handling of
recall, based on category of defects identified in product/batch(es).
In Case of filed products, Head – QA shall consult Head-Regulatory
Affairs on the recall strategy, which shall include:
Decision to recall
Need to inform Marketing, Regulatory bodies and Customers,
Extent of effectiveness checks for recall (whether all consignees are to
be notified)
In case of domestic product recall, the local FDA shall be informed
depending on the class of recall.
21
“Drug safety is
everybody’s
concern”
Thanks

More Related Content

What's hot

Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
AMOGH DANDEKAR
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
Dr. Amsavel A
 
Documentation in pharmaceutical industry
Documentation  in pharmaceutical industryDocumentation  in pharmaceutical industry
Documentation in pharmaceutical industry
PRANJAY PATIL
 
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
RajeswariS12
 
ICH Q9 Quality Risk Management
ICH Q9 Quality Risk ManagementICH Q9 Quality Risk Management
ICH Q9 Quality Risk Management
Seetharam Kandarpa ASQ CMQ/OE, CPGP, CQA
 
CHANGE CONTROL
CHANGE CONTROLCHANGE CONTROL
CHANGE CONTROL
sonia nazir
 
Complaints and recall handling
Complaints and recall handlingComplaints and recall handling
Complaints and recall handling
husna05
 
Investigation of OOS and OOT results
Investigation of OOS and OOT resultsInvestigation of OOS and OOT results
Investigation of OOS and OOT results
Moshfiqur Rahaman
 
Change control
Change controlChange control
Change control
Syeda Abeer
 
c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)
Rohit K.
 
Product Recall.pdf
Product Recall.pdfProduct Recall.pdf
Product Recall.pdf
Md. Zakaria Faruki
 
Dist record 112070804007
Dist  record 112070804007Dist  record 112070804007
Dist record 112070804007
Patel Parth
 
SUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing SurveillanceSUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing Surveillance
MANIKANDAN V
 
Pharmaceutical Complaints
Pharmaceutical ComplaintsPharmaceutical Complaints
Pharmaceutical Complaints
Teny Thomas
 
Packaging material vendor audit
Packaging material vendor auditPackaging material vendor audit
Packaging material vendor audit
RavichandraNadagouda
 
Quality Audit plan and reports
Quality Audit plan and reportsQuality Audit plan and reports
Quality Audit plan and reports
ChetanMali6
 
Snda
SndaSnda
Snda
bdvfgbdhg
 
GMP- APQR training
GMP- APQR  trainingGMP- APQR  training
GMP- APQR training
Amsavel Vel
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. Amsavel
Dr. Amsavel A
 

What's hot (20)

Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
 
Documentation in pharmaceutical industry
Documentation  in pharmaceutical industryDocumentation  in pharmaceutical industry
Documentation in pharmaceutical industry
 
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
 
ICH Q9 Quality Risk Management
ICH Q9 Quality Risk ManagementICH Q9 Quality Risk Management
ICH Q9 Quality Risk Management
 
CHANGE CONTROL
CHANGE CONTROLCHANGE CONTROL
CHANGE CONTROL
 
Complaints and recall handling
Complaints and recall handlingComplaints and recall handling
Complaints and recall handling
 
Investigation of OOS and OOT results
Investigation of OOS and OOT resultsInvestigation of OOS and OOT results
Investigation of OOS and OOT results
 
Change control
Change controlChange control
Change control
 
c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)c gmp (current good manufacturing practices)
c gmp (current good manufacturing practices)
 
Product Recall.pdf
Product Recall.pdfProduct Recall.pdf
Product Recall.pdf
 
Dist record 112070804007
Dist  record 112070804007Dist  record 112070804007
Dist record 112070804007
 
SUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing SurveillanceSUPAC, BACPAC, Post Marketing Surveillance
SUPAC, BACPAC, Post Marketing Surveillance
 
Pharmaceutical Complaints
Pharmaceutical ComplaintsPharmaceutical Complaints
Pharmaceutical Complaints
 
Packaging material vendor audit
Packaging material vendor auditPackaging material vendor audit
Packaging material vendor audit
 
Quality Audit plan and reports
Quality Audit plan and reportsQuality Audit plan and reports
Quality Audit plan and reports
 
Snda
SndaSnda
Snda
 
GMP- APQR training
GMP- APQR  trainingGMP- APQR  training
GMP- APQR training
 
cGMP AS PER USFDA
cGMP AS PER USFDAcGMP AS PER USFDA
cGMP AS PER USFDA
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. Amsavel
 

Similar to Market Complaint Investigation and Recall

COMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical productsCOMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical products
LINGESHMASSLEE007
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IV
SUJITHA MARY
 
Recall of ph product
Recall of ph productRecall of ph product
Recall of ph product
Ahmed Suhail
 
Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...
swrk
 
RECALL.pptx
RECALL.pptxRECALL.pptx
RECALL.pptx
BALASUNDARESAN M
 
A Detailed Study on Pharmaceutical Drug Recall
A Detailed Study on Pharmaceutical Drug RecallA Detailed Study on Pharmaceutical Drug Recall
A Detailed Study on Pharmaceutical Drug Recall
Teny Thomas
 
Compl n recal 112070804013
Compl n recal  112070804013Compl n recal  112070804013
Compl n recal 112070804013
Patel Parth
 
drugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptxdrugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptx
Monishabasavaraj
 
Complaints and recalls himanshu
Complaints and recalls himanshuComplaints and recalls himanshu
Complaints and recalls himanshu
himanshu kamboj
 
Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance
PRASHANT JADHAV
 
Unit 4 Complaints.pptx
Unit 4 Complaints.pptxUnit 4 Complaints.pptx
Unit 4 Complaints.pptx
AshwiniBhoir2
 
Complaints & Recalls
Complaints & RecallsComplaints & Recalls
Complaints & Recalls
Karishma Majik
 
Medical device regulatory ppt
Medical device regulatory pptMedical device regulatory ppt
Medical device regulatory ppt
RohitParkale
 
Colombia INVIMA medical device registration document requirements
Colombia INVIMA medical device registration document requirementsColombia INVIMA medical device registration document requirements
Colombia INVIMA medical device registration document requirements
Julio G. Martinez-Clark
 
Complaint handling-management-cape-town
Complaint handling-management-cape-townComplaint handling-management-cape-town
Complaint handling-management-cape-town
GlobalCompliancePanel
 
Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)
ShrutiBattinwar
 
TGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVDTGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVD
TGA Australia
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
Sigma
 
2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...
2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...
2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...
U.S. Consumer Product Safety Commission
 
FDA regulation for medical devices
FDA regulation for medical devicesFDA regulation for medical devices
FDA regulation for medical devices
Simrana Fathima
 

Similar to Market Complaint Investigation and Recall (20)

COMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical productsCOMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical products
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IV
 
Recall of ph product
Recall of ph productRecall of ph product
Recall of ph product
 
Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...Complaint handling in pharmaceutical companies,product recall,retention recor...
Complaint handling in pharmaceutical companies,product recall,retention recor...
 
RECALL.pptx
RECALL.pptxRECALL.pptx
RECALL.pptx
 
A Detailed Study on Pharmaceutical Drug Recall
A Detailed Study on Pharmaceutical Drug RecallA Detailed Study on Pharmaceutical Drug Recall
A Detailed Study on Pharmaceutical Drug Recall
 
Compl n recal 112070804013
Compl n recal  112070804013Compl n recal  112070804013
Compl n recal 112070804013
 
drugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptxdrugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptx
 
Complaints and recalls himanshu
Complaints and recalls himanshuComplaints and recalls himanshu
Complaints and recalls himanshu
 
Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance Product Complaints and Recall: Quality Assurance
Product Complaints and Recall: Quality Assurance
 
Unit 4 Complaints.pptx
Unit 4 Complaints.pptxUnit 4 Complaints.pptx
Unit 4 Complaints.pptx
 
Complaints & Recalls
Complaints & RecallsComplaints & Recalls
Complaints & Recalls
 
Medical device regulatory ppt
Medical device regulatory pptMedical device regulatory ppt
Medical device regulatory ppt
 
Colombia INVIMA medical device registration document requirements
Colombia INVIMA medical device registration document requirementsColombia INVIMA medical device registration document requirements
Colombia INVIMA medical device registration document requirements
 
Complaint handling-management-cape-town
Complaint handling-management-cape-townComplaint handling-management-cape-town
Complaint handling-management-cape-town
 
Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)
 
TGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVDTGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: Lifecycle of a Medical Device / IVD
 
Medical device regulations 510k
Medical device regulations 510kMedical device regulations 510k
Medical device regulations 510k
 
2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...
2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...
2013 Compliance with Mandatory Reporting Requirements, Regulatory Violations,...
 
FDA regulation for medical devices
FDA regulation for medical devicesFDA regulation for medical devices
FDA regulation for medical devices
 

Recently uploaded

Embyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and ClassificationEmbyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and Classification
Reenaz Shaik
 
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
PVI, PeerView Institute for Medical Education
 
Abnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar punctureAbnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar puncture
Preet Mehta
 
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptxWhy Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
AmandaChou9
 
virus pharmaceutical microbiology .pdf..
virus pharmaceutical microbiology .pdf..virus pharmaceutical microbiology .pdf..
virus pharmaceutical microbiology .pdf..
Bhagyashree Gajbhare
 
Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.
Reenaz Shaik
 
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
PVI, PeerView Institute for Medical Education
 
Minimal Residual Disease (MRD)
Minimal Residual Disease           (MRD)Minimal Residual Disease           (MRD)
Minimal Residual Disease (MRD)
Reenaz Shaik
 
Jurnalul Fericirii Life Care - Iulie 2024
Jurnalul Fericirii Life Care - Iulie 2024Jurnalul Fericirii Life Care - Iulie 2024
Jurnalul Fericirii Life Care - Iulie 2024
Life Care Romania
 
Introduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptxIntroduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptx
Shamsuddin Mahmud
 
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)
Reenaz Shaik
 
General Principles of Law, History and various Acts related to Drugs and Phar...
General Principles of Law, History and various Acts related to Drugs and Phar...General Principles of Law, History and various Acts related to Drugs and Phar...
General Principles of Law, History and various Acts related to Drugs and Phar...
PratibhaSonawane5
 
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdfEligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
Ontotext
 
Metabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptxMetabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptx
apeksha40
 
Male Infertility and Investigations
Male Infertility and InvestigationsMale Infertility and Investigations
Male Infertility and Investigations
Reenaz Shaik
 
RETINAL ARTERY OCCLUSIONS CRAO BRAO CLRAO
RETINAL ARTERY OCCLUSIONS  CRAO   BRAO   CLRAORETINAL ARTERY OCCLUSIONS  CRAO   BRAO   CLRAO
RETINAL ARTERY OCCLUSIONS CRAO BRAO CLRAO
AashishNeupane15
 
Nursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysisNursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysis
shivalingatalekar1
 
Comfort, Rest, Sleep and Pain.pptx
Comfort, Rest, Sleep  and Pain.pptxComfort, Rest, Sleep  and Pain.pptx
Comfort, Rest, Sleep and Pain.pptx
Nandish Sannaiah
 
chemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacychemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacy
KrishnaveniManubolu
 
Abortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in Doha
Abortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in DohaAbortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in Doha
Abortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in Doha
maishakhanam230
 

Recently uploaded (20)

Embyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and ClassificationEmbyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and Classification
 
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
 
Abnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar punctureAbnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar puncture
 
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptxWhy Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
 
virus pharmaceutical microbiology .pdf..
virus pharmaceutical microbiology .pdf..virus pharmaceutical microbiology .pdf..
virus pharmaceutical microbiology .pdf..
 
Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.
 
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
 
Minimal Residual Disease (MRD)
Minimal Residual Disease           (MRD)Minimal Residual Disease           (MRD)
Minimal Residual Disease (MRD)
 
Jurnalul Fericirii Life Care - Iulie 2024
Jurnalul Fericirii Life Care - Iulie 2024Jurnalul Fericirii Life Care - Iulie 2024
Jurnalul Fericirii Life Care - Iulie 2024
 
Introduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptxIntroduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptx
 
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)
 
General Principles of Law, History and various Acts related to Drugs and Phar...
General Principles of Law, History and various Acts related to Drugs and Phar...General Principles of Law, History and various Acts related to Drugs and Phar...
General Principles of Law, History and various Acts related to Drugs and Phar...
 
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdfEligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
 
Metabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptxMetabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptx
 
Male Infertility and Investigations
Male Infertility and InvestigationsMale Infertility and Investigations
Male Infertility and Investigations
 
RETINAL ARTERY OCCLUSIONS CRAO BRAO CLRAO
RETINAL ARTERY OCCLUSIONS  CRAO   BRAO   CLRAORETINAL ARTERY OCCLUSIONS  CRAO   BRAO   CLRAO
RETINAL ARTERY OCCLUSIONS CRAO BRAO CLRAO
 
Nursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysisNursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysis
 
Comfort, Rest, Sleep and Pain.pptx
Comfort, Rest, Sleep  and Pain.pptxComfort, Rest, Sleep  and Pain.pptx
Comfort, Rest, Sleep and Pain.pptx
 
chemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacychemical kinetics part 1 mkv ppt pharmacy
chemical kinetics part 1 mkv ppt pharmacy
 
Abortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in Doha
Abortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in DohaAbortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in Doha
Abortion pills for sale in Qatar(+919707208804)Buy Cytotec tablet in Doha
 

Market Complaint Investigation and Recall

  • 1. MARKET COMPLAINTS INVESTIGATION AND RECALL DHANJAY KUMAR SINGH (Sr. Executive QA) SIMPEX PHARMA PVT. LTD., KOTDWAR
  • 2. 2 MARKET COMPLAINTS INTRODUCTION A complaint is an objection to something that is unfair, unacceptable, or otherwise not up to normal standards.  Complaints may be about Services, Delivery, Quality of Product, Communication, Response, Time, Documentation, Billing, Follow up etc.  Complaint is any communication written or verbal, received directly from any customer, retailer, distributor, or representative of contract giver, regarding the quality attributes, labelling defects or any other matter such complaints shall be considered as market complaints.
  • 3. 3 Handling of Product Complaints Section 820.3(b) of the Quality Systems regulation defines a complaint as "any written, electronic, or oral communication that alleges deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance of a device after it is released for distribution”. We (Simpex) define complaint as – “any written or verbal communication received from any customer including qualified personnel, pharmacy, retailer, distributor, or regulatory authorities regarding the purity, safety, strength, efficacy, labeling, shortage or any other issue which claim to be related to the quality of the product/packing in the opinion of the complainer”.
  • 4. 4 Why do customers complain? Their expectations have not been met…! When the customer pays for a product or service, it is assumed that the product will work correctly or that the service received is as promised. Ideally, the customer will be satisfied, and there will be no complaints.
  • 5. 5  It gives the company an opportunity to improve the quality of the product It is helpful to maintain cGMP It maintains committed relationship between the customer and company It is the regulatory obligation. NEED FOR COMPLAINT HANDLING SYSTEM
  • 6. Classification of complaints A-Type Complaints Critical complaints in which product is required to be withdrawn from the market. (Primary Response shall be given within working hours of same day of the receipt of market complaint) Such as • Adverse Drug Reaction. • Major health hazard causing permanent deficiency or death. • Purity & Safety. • Potency. • Product Stability
  • 7. Classification of complaints B-Type Complaints Major complaints (Primary response to Major defects shall be given within 24 hours of the receipt of the market complaint) such as • Problem with primary packaging of the product. • Chemical / Physical attributes of the product. • Extraneous contamination, mix-ups, etc.
  • 8. Classification of complaints C-Type Complaints Minor complaints (Primary response to Major defects shall be given within 72 hours of the receipt of the market complaint) such as • Problem related to labelling / coding of batch details. • Shortages. • Secondary packaging material problem, etc.
  • 9. 9 ComplaintsHandling STEPS INVOLVED IN HANDLING OF COMPLAINTS Step I: Receiving Step II: Investigation Step III: Corrective Actions Step IV: Feedback to Customers
  • 10. 10 Complaint flow at manufacturing unit … Reporting Track action Acknowledgment Team formation Investigation Sample check Record review Machine review Expert advice Action Investigation report Response
  • 12. 12 PRODUCT RECALL Recalls are actions taken to remove a product from the market and restrict further distribution and sale – Simpex (SQA013) A recall is when a product is removed from the market… because it is either defective or potentially harmful. – US FDA Permanent removal of therapeutic goods from supply or use for reasons relating to deficiencies in the quality, safety or efficacy of goods. – Therapeutic Goods Administration, Australia
  • 13. 13 PRODUCT RECALL There should be a system to recall from the market, promptly and effectively, products known or suspected to be defective. – WHO In order to protect public health… necessary to implement urgent measures such as the recall of one or more defective batch(es) of a medicinal product from the market. – European Medicines Agency (EMA)
  • 14. 14 RECALL CLASSIFICATION Class 1 Recall Situation in which there is a reasonable probability that the use or exposure to the product will cause serious adverse health consequences or death.
  • 15. 15 RECALL CLASSIFICATION Class 2 Recall Situation in which use or exposure to the product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
  • 16. 16 RECALL CLASSIFICATION Class 3 Recall Situation in which use or exposure to the product is not likely to cause adverse health consequences.
  • 17. 17 DURATION OF RECALL OPERATION  Class 1 Recall – Within 24hr to Maximum 72 hr.  Class 2 Recall – Within 10 days  Class 3 Recall – Within 30 days
  • 18. 18 TYPE OF RECALL  VOLUNTARY RECALL: This is recall of product from the market or distribution network of entire available quantity at the time of initiation of recall, based on decision by Recall Management Committee. This could be because of: quality complaint from market, or discovery of some deficiency, or stability problem subsequent to dispatch, or unsold stocks (short expiry) FORCED RECALL: This is recall forced by a regulatory agency upon discovery / reporting of violation or deficiency in the product.
  • 20. 20 PRODUCT RECALL  Head QA shall take the decision on recall in consultation with management of firm including key personnel involved in handling of recall, based on category of defects identified in product/batch(es). In Case of filed products, Head – QA shall consult Head-Regulatory Affairs on the recall strategy, which shall include: Decision to recall Need to inform Marketing, Regulatory bodies and Customers, Extent of effectiveness checks for recall (whether all consignees are to be notified) In case of domestic product recall, the local FDA shall be informed depending on the class of recall.